29.07.2008 ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008

28.07.2008 Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14

25.07.2008 Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial

24.07.2008 Genentech Forms Special Committee of Independent Directors to Review Roche Proposal

21.07.2008 Genentech Announces Receipt of Proposal From Roche

17.07.2008 Amgen Announces Webcast of 2008 Second Quarter Financial Results

15.07.2008 18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto

15.07.2008 Study Showed Half of Patients Treated with Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had No Progression of Joint Damage in Active Early Rheumatoid Arthritis

14.07.2008 Genentech Announces Second Quarter 2008 Results

14.07.2008 Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy

11.07.2008 Amgen and Ortho Biotech Settle Antitrust Suit

10.07.2008 Amgen Commits to PhRMA's Enhanced Code on Interactions with Healthcare Professionals as Part of the Company's 'Clearly Amgen' Initiative

07.07.2008 Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology